Do we Have the Gut to Beat Thrombosis?
Seminars in Thrombosis and Hemostasis · 01.03.2026 · 52 (02) · 209-218
DOI: 10.1055/a-2704-8487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.03.2026. Verfasst von Konstantina Tsante und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Haematology and Blood Bank Unit, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athen…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Thrombosis. Die Arbeit nennt 62 Literaturangaben.
Abstract (Originalsprache)
Arterial and venous thromboembolism represent major contributors to global morbidity and mortality. Despite substantial progress in risk stratification and clinical management, a significant proportion of thromboembolic events occur in individuals not classified within traditional high-risk groups indicating the involvement of additional, non-conventional risk factors in thrombotic pathophysiology. Recent evidence has highlighted the gut microbiome as a critical determinant of human health, with increasing recognition of its role in cardiovascular and thrombotic disorders. Furthermore, the gut microbiome constitutes a modifiable risk factor, offering new horizons for therapeutic intervention and emerging evidence suggests that alterations in the microbiome may significantly impact thrombotic risk. Moreover, microbiome-derived metabolites have gathered considerable scientific attention for their potential involvement in the initiation and progression of thrombosis. These metabolites may serve as novel biomarkers, complementing conventional risk indicators in disease diagnosis, prognosis, screening, and patient monitoring. Microbiome-derived metabolites may hold dual utility, first as diagnostic and prognostic biomarkers, and, second, as potential targets for pharmacologic modulation. Collectively, these findings underscore the growing significance of the gut microbiome as an environmental factor in thromboembolic disease and justify the constantly increasing employment of the scientific community in several aspects of health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Haematology and Blood Bank Unit, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Neonatal Intensive Care Unit, "Agios Panteleimon" General Hospital of Nikea, Piraeus, Greece.
- Medical School, University of Cyprus, Nicosia, Cyprus.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- IRCCS Humanitas Research Hospital, Milan, Italy.
- Neonatal Department, National and Kapodistrian University of Athens, Aretaieio Hospital, Athens, Greece.
ORCID-Profile: Andreas G Tsantes, Alexandra Lianou
Zitieren
APA
Tsante, K., Petrou, E., Tsalas, S., Tsantes, A. G., Lianou, A., Kartelias, G., Kyriakou, E., Kokoris, S., Nikolopoulos, G., Bonovas, S., & Sokou, R. (2026). Do we Have the Gut to Beat Thrombosis?. Seminars in Thrombosis and Hemostasis, 52(02), 209-218. https://doi.org/10.1055/a-2704-8487
Vancouver
Tsante K, Petrou E, Tsalas S, Tsantes AG, Lianou A, Kartelias G, et al. Do we Have the Gut to Beat Thrombosis?. Seminars in Thrombosis and Hemostasis. 2026;52(02):209-218. doi:10.1055/a-2704-8487
BibTeX
@article{Tsante2026,
author = {Tsante, Konstantina and Petrou, Eleni and Tsalas, Stavros and Tsantes, Andreas G and Lianou, Alexandra and Kartelias, Georgios and Kyriakou, Elias and Kokoris, Styliani and Nikolopoulos, Georgios and Bonovas, Stefanos and Sokou, Rozeta},
title = {Do we Have the Gut to Beat Thrombosis?},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2026},
volume = {52},
number = {02},
pages = {209--218},
doi = {10.1055/a-2704-8487}
}
EUVIMED